Relapsed NLPHL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) (NCT01187303) | University of Cologne | 2011-05-01 |
Track Relapsed NLPHL automatically
Every clearance here is in the API, with alerts when new ones post.